Pulmonary Embolism Drug Market Outlook, Demand, Growth, Consumption, Analysis of Leading Players GlaxoSmithKline, Johnson & Johnson, Accu-Break
According to the Centers for Disease Control and Prevention estimation, there are around 900,000 people afflicted by Pulmonary Embolism (PE) or Deep Vein Thrombosis (DVT), 1 or 2 per 1,000 individuals each year are affected in the United States. PE is a sudden blockage in a lung artery which is caused by a blood clot that travels to the lung from a vein in the leg, also known as deep vein thrombosis. A clot that forms in one part of...
View full press release